5 days ago · ... novel diagnostic biomarker panel for Alzheimers in the Egyptian population. ... Jellinger KA (2018) Dementia with Lewy bodies and Parkinson's disease-dementia ...

6 days ago · CNTNs were measured in 82 CSF samples from patients with Alzheimer's disease (AD, n = 19), behavioural variant frontotemporal dementia (bvFTD, n = 18), ...

6 days ago · ... diagnosis of Lewy body dementia from AD [185, 186]. In ... Novel candidate biomarkers spanning various pathways, including amyloid metabolism (CSF Aβ38 ...

3 days ago · [38]. A. Rentsendorj, J. Sheyn, D.T. Fuchs, et al. A novel role for osteopontin in macrophage-mediated amyloid-β clearance in Alzheimer's models. Brain Behav ...

6 days ago · The pathological progression of AD involves not only the classical hallmarks of amyloid beta (Aβ) plaque buildup and neurofibrillary tangle development but also ...

3 days ago · In our tertiary memory clinic, the standard CSF biomarker panel consists of Amyloid Beta. (AB) 42, Total tau, and Phosphorylated tau. AB42/40 is an ...

2 days ago · Agreement of cerebrospinal fluid biomarkers and amyloid ... Platelet miRNA Biosignature Discriminates between Dementia with Lewy Bodies and Alzheimer's Disease.

6 days ago · They all lead to a dramatic reduction of amyloid plaques in the brain, whereas their clinical effects have been more limited. Moreover, they can all lead to ...

2 days ago · It is characterized by the accumulation of beta-amyloid and ... dementia: a comparison with alzheimer's disease, dementia with lewy bodies and controls.

6 days ago · dementia of Alzheimer disease. An ... The pathophysiology of Parkinson disease includes dopa- minergic neuron death and accumulation of Lewy bodies asso-.